Teva Pharmaceutical Industries (TEVA) Treasury Shares (2009 - 2026)
Teva Pharmaceutical Industries' (TEVA) quarterly Treasury Shares came in at $4.1 billion in Q2 2026, little changed YoY from $4.1 billion in Q2 2025, and little changed on a QoQ basis from $4.1 billion in Q1 2026.
Teva Pharmaceutical Industries (TEVA) Treasury Shares (2009 - 2026) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has 18 years of Treasury Shares data on file, last reported at $4.1 billion in Q2 2026.
- Quarterly Treasury Shares changed 0.0% year-over-year to $4.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.1 billion (changed 0.0% YoY) and the FY2025 annual result came in at $4.1 billion, changed 0.0% from the prior year.
- Treasury Shares steadied at $4.1 billion in Q2 2026, from $4.1 billion in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $107.0 million in Q4 2024 to a low of $32.3 million in Q4 2022.
- A 5-year average of $98.2 million and a median of $106.0 million in 2022 frame the typical range for Treasury Shares.
- The widest YoY moves for Treasury Shares: up 0.0% in 2022, down 0.0% in 2022.
- Tracing TEVA's Treasury Shares over 5 years: stood at $4.1 billion in 2022, then changed by 0.0% to $4.1 billion in 2023, then changed by 0.0% to $4.1 billion in 2024, then changed by 0.0% to $4.1 billion in 2025, then changed by 0.0% to $4.1 billion in 2026.
- The last three Treasury Shares figures came in at $4.1 billion (Q2 2026), $4.1 billion (Q1 2026), and $4.1 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 19.00 Mn |
| 10 | Alkermes | 8.09 Bn | 7.43 Bn | 397.90 Mn | 502.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 106.00 Mn |
| Jun 30, 2026 | 106.00 Mn |
| Jun 30, 2026 | 4.13 Bn |
| Jun 30, 2026 | 4.13 Bn |
| Mar 31, 2026 | 4.13 Bn |
| Mar 31, 2026 | 4.13 Bn |
| Mar 31, 2026 | 107.00 Mn |
| Mar 31, 2026 | 107.00 Mn |
| Dec 31, 2025 | 107.00 Mn |
| Dec 31, 2025 | 107.00 Mn |
| Dec 31, 2025 | 4.13 Bn |
| Dec 31, 2025 | 4.13 Bn |
| Sep 30, 2025 | 106.00 Mn |
| Sep 30, 2025 | 106.00 Mn |
| Sep 30, 2025 | 4.13 Bn |
| Sep 30, 2025 | 4.13 Bn |
| Jun 30, 2025 | 4.13 Bn |
| Jun 30, 2025 | 106.00 Mn |
| Jun 30, 2025 | 106.00 Mn |
| Jun 30, 2025 | 4.13 Bn |